Proinflammatory CD20(+) T Cells are Differentially Affected by Multiple Sclerosis Therapeutics. Quendt C, Ochs J, Hausser-Kinzel S, Hausler D, et al. Ann Neurol 2021;90:834-839.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Quendt C, Ochs J, Hausser-Kinzel S, Hausler D, et al. Proinflammatory CD20(+) T Cells are Differentially Affected by Multiple Sclerosis Therapeutics. Ann Neurol 2021;90:834-839.
PMID: 34516013